Item 5. Other Information
Item 5. Other Information.
None.
33
Table of Contents
Item 6. E xhibits.
Incorporated by Reference
Exhibit
Number
Description
Form
Exhibit
Number
Filing Date
Filed or
Furnished
Herewith
3.1
Restated Certificate of Incorporation
8-K
3.1
6/7/21
3.2
Amended and Restated Bylaws
8-K
3.2
9/22/15
10.1†
Letter Agreement dated March 21, 2022 between the Company and The Trustees of the University of Pennsylvania
X
31.1
Certification of the Chief Executive Officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002
X
31.2
Certification of the Chief Financial Officer as required by Section 302 of the Sarbanes-Oxley Act of 2002
X
32.1
Certifications of the Chief Executive Officer and Chief Financial Officer as required by 18 U.S.C. 1350
X
101
The following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 formatted in Inline XBRL (eXtensible Business Reporting Language):
(i) Consolidated Balance Sheets
(ii) Consolidated Statements of Operations and Comprehensive Loss
(iii) Consolidated Statements of Stockholders’ Equity
(iv) Consolidated Statements of Cash Flows
(v) Notes to Consolidated Financial Statements
X
104
The cover page from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 formatted in Inline XBRL (included in Exhibit 101)
† Portions of this exhibit have been omitted.
The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the SEC and is not to be incorporated by reference into any filing of REGENXBIO Inc. under the Securities Act or the Exchange Act, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
34
Table of Contents
SIGNA TURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
REGENXBIO Inc.
Dated: May 4, 2022
/s/ Kenneth T. Mills
Kenneth T. Mills
President and Chief Executive Officer
(Principal Executive Officer)
Dated: May 4, 2022
/s/ Vittal Vasista
Vittal Vasista
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
35
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.